The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States
Open accessAbstract
Purpose: To estimate the overall survival (OS) impact from increasing time to treatment initiation (TTI) for patients with head and neck squamous cell carcinoma (HNSCC). Methods: Using the National Cancer Data Base (NCDB), we examined patients who received curative therapy for the following sites: oral tongue, oropharynx, larynx, and hypopharynx. TTI was the number of days from diagnosis to initiation of curative treatment. The effect of TTI on OS was determined by using Cox regression models (MVA). Recursive partitioning analysis (RPA) identified TTI thresholds via conditional inference trees to estimate the greatest differences in OS on the basis of randomly selected training and validation sets, and repeated this 1,000 times to ensure robustness of TTI thresholds. Results: A total of 51,655 patients were included. On MVA, TTI of 61 to 90 days versus less than 30 days (hazard ratio [HR], 1.13; 95% CI, 1.08 to 1.19) independently increased mortality risk. TTI of 67 days appeared as the optimal threshold on the training RPA, statistical significance was confirmed in the validation set (P < .001), and the 67-day TTI was the optimal threshold in 54% of repeated simulations. Overall, 96% of simulations validated two optimal TTI thresholds, with ranges of 46 to 52 days and 62 to 67 days. The median OS for TTI of 46 to 52 days or fewer versus 53 to 67 days versus greater than 67 days was 71.9 months (95% CI, 70.3 to 73.5 months) versus 61 months (95% CI, 57 to 66.1 months) versus 46.6 months (95% CI, 42.8 to 50.7 months), respectively (P < .001). In the most recent year with available data (2011), 25% of patients had TTI of greater than 46 days. Conclusion: TTI independently affects survival. One in four patients experienced treatment delay. TTI of greater than 46 to 52 days introduced an increased risk of death that was most consistently detrimental beyond 60 days. Prolonged TTI is currently affecting survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Harrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tân, P. F., Westra, W. H., Chung, C. H., Jordan, R. C., Lu, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912217 · Cited by 6,566
Hospital Volume and Surgical Mortality in the United States
Birkmeyer, J. D., Siewers, A. E., Finlayson, E. V. A., Stukel, T. A., Lucas, F. L., Batista, I., Welch, H. G., & Wennberg, D. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa012337 · Cited by 4,999
A note on quantifying follow-up in studies of failure time
Schemper, M., & Smith, T. L. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(96)00075-x · Cited by 2,575
Pignon, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)90011-0 · Cited by 2,543
Leavitt, M. (2001) · PubMed · Cited by 1,872
The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States
Bilimoria, K. Y., Stewart, A. K., Winchester, D. P., & Ko, C. Y. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9747-3 · Cited by 1,851
Cancer Disparities by Race/Ethnicity and Socioeconomic Status
Ward, E., Jemal, A., Cokkinides, V., Singh, G. K., Cardinez, C., Ghafoor, A., & Thun, M. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.2.78 · Cited by 1,801
Nutting, C. M., Morden, J. P., Harrington, K. J., Urbano, T. G., Bhide, S. A., Clark, C., Miles, E. A., Miah, A. B., Newbold, K., Tanay, M., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70290-4 · Cited by 1,706
Pulte, D., & Brenner, H. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0289 · Cited by 849
Pignon, J. P., Bourhis, J., Domenge, C., & Designe, L. (2001) · Cancer/Radiothérapie · doi:10.1016/s1278-3218(00)00073-1 · Cited by 700
Ang, K. K., Trotti, A., Brown, B. W., Garden, A. S., Foote, R. L., Morrison, W. H., Geara, F. B., Klotch, D. W., Goepfert, H., & Peters, L. J. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01690-x · Cited by 637
O'Sullivan, B., Huang, S. H., Siu, L. L., Waldron, J., Zhao, H., Perez-Ordonez, B., Weinreb, I., Kim, J., Ringash, J., Bayley, A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.0164 · Cited by 592
Cancer Mortality in the United States by Education Level and Race
Albano, J. D., Ward, E., Jemal, A., Anderson, R., Cokkinides, V. E., Murray, T., Henley, J., Liff, J., & Thun, M. J. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djm127 · Cited by 469
Predictors of Competing Mortality in Advanced Head and Neck Cancer
Mell, L. K., Dignam, J. J., Salama, J. K., Cohen, E. E. W., Polite, B. N., Dandekar, V., Bhate, A. D., Witt, M. E., Haraf, D. J., Mittal, B. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.9288 · Cited by 433
Relative Risk Trees for Censored Survival Data
LeBlanc, M., & Crowley, J. (1992) · Biometrics · doi:10.2307/2532300 · Cited by 421
Merino, O. R., Lindberg, R. D., & Fletcher, G. H. (1977) · Cancer · doi:10.1002/1097-0142(197707)40:1<145::aid-cncr2820400124>3.0.co;2-9 · Cited by 417
Wait Times for Cancer Surgery in the United States: Trends and Predictors of Delays
Bilimoria, K. Y., Ko, C. Y., Tomlinson, J. S., Stewart, A. K., Talamonti, M. S., Hynes, D. L., Winchester, D. P., & Bentrem, D. J. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e318211cc0f · Cited by 315
Tumor progression in waiting time for radiotherapy in head and neck cancer
Jensen, A. R., Nellemann, H. M., & Overgaard, J. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.04.001 · Cited by 309
Institutional Clinical Trial Accrual Volume and Survival of Patients With Head and Neck Cancer
Wuthrick, E. J., Zhang, Q., Machtay, M., Rosenthal, D. I., Nguyen-Tan, P. F., Fortin, A., Silverman, C. L., Raben, A., Kim, H. E., Horwitz, E. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.5218 · Cited by 250
Murphy, C. T., Galloway, T. J., Handorf, E. A., Wang, L., Mehra, R., Flieder, D. B., & Ridge, J. A. (2014) · Cancer · doi:10.1002/cncr.29191 · Cited by 156
Self-citationSeoane, J., Takkouche, B., Varela‐Centelles, P. I., Tomás, I., & Romero, J. M. (2012) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2012.02464.x · Cited by 144
Chen, A. Y., Fedewa, S. A., Pavluck, A., & Ward, E. (2010) · Cancer · doi:10.1002/cncr.25364 · Cited by 144
Smith, B. D., Haffty, B. G., Wilson, L. D., Smith, G. L., Patel, A. N., & Buchholz, T. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.2520 · Cited by 142
Shavers, V. L., Harlan, L. C., Winn, D. M., & Davis, W. W. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1022255800411 · Cited by 140
Waaijer, A., Terhaard, C. H. J., Dehnad, H., Hordijk, G. J., van Leeuwen, M. S., Raaymakers, C. J. P., & Lagendijk, J. J. W. (2003) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(03)00036-7 · Cited by 136
Influence of time delay and clinical upstaging in the prognosis of head and neck cancer
Kowalski, L. P., & Carvalho, A. L. (2001) · Oral Oncology · doi:10.1016/s1368-8375(00)00066-x · Cited by 135
Delay in the diagnosis of oral squamous cell carcinoma
Wildt, J., Bundgaard, T., & Bentzen, S. M. (1995) · Clinical Otolaryngology · doi:10.1111/j.1365-2273.1995.tb00006.x · Cited by 127
Crawford, S., Davis, J. A., Siddiqui, N. A., de Caestecker, L., Gillis, C. R., Hole, D., & Penney, G. (2002) · BMJ · doi:10.1136/bmj.325.7357.196 · Cited by 124
Predictive Factors for Diagnosis of Advanced-Stage Squamous Cell Carcinoma of the Head and Neck
Carvalho, A. L., Pintos, J., Schlecht, N. F., Oliveira, B. V., Fava, A. S., Curado, M. P., Kowalski, L. P., & Franco, E. L. (2002) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.128.3.313 · Cited by 106
Oral and pharyngeal cancer: Analysis of patient delay at different tumor stages
Brouha, X. D. R., Tromp, D. M., Hordijk, G. J., Winnubst, J. A. M., & de Leeuw, J. R. J. (2005) · Head & Neck · doi:10.1002/hed.20270 · Cited by 104
Comorbidity and diagnostic delay in cancer of the larynx, tongue and pharynx
Teppo, H., & Alho, O. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2008.10.012 · Cited by 95
Lyhne, N. M., Christensen, A., Alanin, M. C., Bruun, M. T., Jung, T. H., Bruhn, M. A., Jespersen, J., Kristensen, C. A., Andersen, E., Godballe, C., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.11.034 · Cited by 74
Delays in treatment in the cancer services: impact on cancer stage and survival.
Comber, H., Cronin, D., Deady, S., Lorcain, P. O., & Riordan, P. (2005) · PubMed · Cited by 67
Tromp, D. M., Brouha, X. D. R., Hordijk, G. J., Winnubst, J. A. M., & de Leeuw, J. R. J. (2005) · Family Practice · doi:10.1093/fampra/cmi058 · Cited by 66
Teppo, H., Koivunen, P. T., Hyrynkangas, K., & Alho, O. (2002) · Head & Neck · doi:10.1002/hed.10208 · Cited by 64
Role of alcohol and smoking in diagnostic delay of head and neck cancer patients
Brouha, X. D. R., Tromp, D. M., Hordijk, G. J., Winnubst, J. A. M., & de Leeuw, R. (2005) · Acta Oto-Laryngologica · doi:10.1080/00016480510028456 · Cited by 60
Professional delay in head and neck cancer patients: Analysis of the diagnostic pathway
Brouha, X. D. R., Tromp, D. M., Koole, R., Hordijk, G. J., Winnubst, J. A. M., & de Leeuw, J. R. J. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2006.06.002 · Cited by 58
Primdahl, H., Nielsen, A. L., Larsen, S., Andersen, E., Ipsen, M., Lajer, C. B., Vestermark, L. W., Andersen, L. J., Hansen, H. S., Overgaard, M., et al. (2006) · Acta Oncologica · doi:10.1080/02841860500423948 · Cited by 47
Growth in the Use of PET for Six Cancer Types After Coverage by Medicare: Additive or Replacement?
Hillner, B. E., Tosteson, A. N. A., Song, X., Tosteson, T. D., Onega, T., Goodman, D. C., & Siegel, B. A. (2012) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2011.06.019 · Cited by 45
Determinants of patient delay in doctor consultation in head and neck cancers (Protocol DEREDIA)
Christophe, V., Leroy, T., Seillier, M., Duthilleul, C., Juliéron, M., Clisant, S., Foncel, J., Vallet, F., & Lefebvre, J. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005286 · Cited by 21
Cited by
Mortality due to cancer treatment delay: systematic review and meta-analysis
Hanna, T. P., King, W. D., Thibodeau, S., Jalink, M., Paulin, G. A., Harvey-Jones, E., O’Sullivan, D. E., Booth, C. M., Sullivan, R., & Aggarwal, A. (2020) · BMJ · doi:10.1136/bmj.m4087 · Cited by 1,742
Prevalence of oral potentially malignant disorders: A systematic review and meta‐analysis
Mello, F. W., Miguel, A. F. P., Dutra, K. L., Porporatti, A. L., Warnakulasuriya, S., Guerra, E. N. S., & Rivero, E. R. C. (2018) · Journal of Oral Pathology & Medicine · doi:10.1111/jop.12726 · Cited by 462
Clinical Practice Guideline: Hoarseness (Dysphonia) (Update)
Stachler, R. J., Francis, D. O., Schwartz, S. R., Damask, C. C., Digoy, G. P., Krouse, H. J., McCoy, S. J., Ouellette, D. R., Patel, R. R., Reavis, C. (. W., et al. (2018) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599817751030 · Cited by 368
Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue
Zhou, R.-S., Zhang, E.-X., Sun, Q.-F., Ye, Z.-J., Liu, J.-W., Zhou, D.-H., & Tang, Y. (2019) · BMC Cancer · doi:10.1186/s12885-019-5983-8 · Cited by 336
Graboyes, E. M., Kompelli, A. R., Neskey, D. M., Brennan, E., Nguyen, S., Sterba, K. R., Warren, G. W., Hughes-Halbert, C., Nussenbaum, B., & Day, T. A. (2019) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2018.2716 · Cited by 312
Metadata
- Authors
- Murphy, C. T., Galloway, T. J., Handorf, E. A., Egleston, B. L., Wang, L. S., Mehra, R., Flieder, D. B., & Ridge, J. A.
- Venue
- Journal of Clinical Oncology
- Published
- 2016-01-10
- Volume
- 34
- Issue
- 2
- Pages
- 169-178
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2183740920
- Cited by
- 428
- References
- 42
- FWCI
- 22.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.